IL-3 was able to significantly increase PD-L1 expression in primary tumours (Figure 7A,B), as well as the number of lung lesions and the magnitude of the scattered PD-L1-positive tumour cells in the lung (Figure 7C–H). This evidence concerns the gene IL3 and neoplasm.